NCT00281853View on ClinicalTrials.gov

Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
NeurotoxicityUnspecified Adult Solid Tumor, Protocol Specific
Interventions
PROCEDURE

management of therapy complications

Patients undergo a 1-hour peripheral nerve function assessment, including hearing, vibratory sensation, and blood pressure testing, at baseline and then at 4, 8, and 12 weeks during treatment with chemotherapy or biologic therapy.

Trial Locations (1)

44106-5065

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00281853 - Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer | Biotech Hunter | Biotech Hunter